The Causal Gap: Timing, Confounding, and Mixed Exposures

A human study can find more microplastics and nanoplastics in people with a health condition without proving that the particles caused it. This chapter examines that gap directly. It gives you a way to test an MNP association—by asking about timing, measurement, comparison groups, alternative causes, and mixtures—before accepting either a reassuring or an alarming conclusion.

An association is a symptom that needs a differential diagnosis

The first review’s human studies are valuable because they observe people rather than only cells or animals. They also inherit the difficulty of observing an exposure that cannot be assigned at random and a health outcome shaped by many parts of life. The question is not whether an association is “real” in the narrow statistical sense. The question is what process could have produced it.

Start with temporality: did the exposure occur before the outcome? Most of the human MNP studies were cross-sectional or retrospective. They measured a particle burden and a health state at one point in time. That design can reveal that the two are found together, but it cannot show which came first. If people with a gastrointestinal condition have a different fecal MNP measurement, the particles might contribute to the condition, the condition might alter what is retained or excreted, or a third factor might influence both. The measurement is a snapshot, not a sequence.

Case–control studies provide a comparison between people with a condition and people without it, but the comparison does not automatically solve the timing problem. Participants may differ in diet, work, product use, treatment, or other environmental exposures. If those differences are related to both MNP burden and the health outcome, the observed contrast can be partly or wholly explained by them. A comparison group is most useful when it represents the relevant alternative state and when the factors that differ between groups are measured and considered.

A prospective cohort is stronger for temporal reasoning because exposure can be measured before a later outcome is recorded. The human review included one prospective cohort, but one study with follow-up cannot supply all the evidence missing from a field dominated by snapshots. Exposure still has to be measured reliably, the cohort still has to be relevant to the population of interest, and other causes still need attention. A quasi-experimental study can examine a change in exposure or circumstance, but it is not automatically a randomized test in which every other influence is balanced.

The second question is confounding. A confounder is a factor associated with both the exposure and the outcome that can distort their apparent relationship. In MNP research, diet is an obvious example. Food choices can affect contact with packaging and can independently affect the gut, weight, metabolism, or inflammation. Body mass, physical activity, occupation, environmental conditions, genetics, and other pollutants can also matter. The human review notes that seven of nine gastrointestinal studies did not control for diet, body mass, and exercise. That omission does not prove the reported gut associations are false. It makes their size and interpretation less secure.

Co-exposure is not just another confounder. It can be part of the biological exposure itself.